Usage, dosage and best time of taking osimertinib mesylate (Tagressa)

Osimertinib mesylate (Osimertinib) is a targeted therapy for the treatment of non-small cell lung cancer (NSCLC), especially those with advanced NSCLC patients with epidermal growth factor receptor (EGFR) mutations. Correct usage, dosage and optimal time of administration are crucial to the efficacy and safety of the drug.

1.Usage and dosage:

Dosage form: Osimertinib mesylate is usually supplied in tablet form, suitable for oral administration.

Recommended dose: Generally, the recommended dose for adult patients is 80 mg (mg) once daily. Medications are usually recommended to be taken orally at the same time each day to ensure stable drug concentrations.

Duration of medication: Patients usually need to continue taking osimertinib mesylate until disease progression or intolerable adverse reactions occur. The doctor will decide whether to continue using the drug based on the patient's specific situation and disease progression.

2.Best time to take:

Taking after meals: Patients are generally advised to take osimertinib mesylate after meals. Taking it after meals can reduce the occurrence of adverse gastrointestinal reactions and help improve the absorption efficiency of the drug.

Taking it at a fixed time: In order to ensure the stability and continuity of the drug, it is recommended that patients take osimertinib mesylate orally at a fixed time every day. The patient can choose a fixed time point every day, such as morning, noon or evening, and take medicine at this time point.

3.Notes:

Take as directed by your doctor: Patients should strictly follow the doctor's or pharmacist's advice and take the prescribed medication in accordance with the usage and dosage. Do not change the dosage or medication time unless directed by your doctor.

Don’t forget to take your medicine: To ensure the effectiveness of the medicine, patients should try to avoid missing medicine. If you accidentally miss a dose, you should continue taking it at the next normal medication time without double dose compensation.

Regular follow-up visits: Patients should have regular follow-up visits during the medication period and receive monitoring and evaluation by doctors. The doctor will adjust the treatment plan according to the patient's condition and drug response to ensure the best treatment effect and safety.

4.Medicine for special groups:

Patients with Impaired Hepatic Function: In patients with impaired hepatic function, the dose of osimertinib mesylate may need to be adjusted. The doctor will decide whether the dose needs to be adjusted based on the patient's specific situation.

Elderly patients: Elderly patients may have a certain degree of influence on the metabolism and excretion of the drug, so dosage adjustments may be necessary in elderly patients.

5.Drug storage:

Osimertinib mesylate should be stored in a cool, dry place away from children and pets. Unused medicines should be disposed of properly and should not be thrown away or dumped.

To sum up, the correct usage, dosage and optimal taking time of osimertinib mesylate are crucial to the therapeutic effect and safety of patients. Patients should strictly follow the doctor's or pharmacist's advice and return regularly for monitoring and evaluation to ensure the best efficacy and safety of the drug.